Senior insider sale
SVP, Chief Technical Officer at ALLOGENE THERAPEUTICS, INC. — senior position signals high conviction
$958.94
786.00 shares
What this filing means
BENESKI BENJAMIN MACHINAS plans to sell 786.00 shares of ALLOGENE THERAPEUTICS, INC. valued at approximately $958.94. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/17/2025ACC: 0002057918-25-000002
Officer· SVP, Chief Technical Officer
Since Mar 2026
786.00
Shares to sell
$958.94
Approx. market value
786.00
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Vesting of restricted stock unit award
Granted as part of issuer equity compensation plan
11/15/2025
786.00Total acquired786.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/15/2025 | Vesting of restricted stock unit award Granted as part of issuer equity compensation plan | 786.00 | — |
| Total | 786.00 | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
786.00
Market value
$958.94
11/17/2025
Total
Units
786.00
Value
$958.94
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
11/17/2025 | 786.00 | $958.94 | NASDAQ | Planned |
| Total | 786.00 | $958.94 | ||